BioCentury
ARTICLE | Clinical News

Quadramet: Updated Phase I data

July 2, 2007 7:00 AM UTC

Updated data from the dose-escalation U.S. Phase I VELSAM2 trial in 32 evaluable patients with relapsed or refractory MM showed that 15 patients achieved a response or disease stabilization after trea...